GSK US retweetledi
News for #Investors and #Media
Explore the key highlights from our Q1 2026 results announcement ⤵️
Find out more: gsk.to/4uelV7Y $GSK
English
GSK US
11.1K posts
GSK US
@GSKUS
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://t.co/woIbYTUlEv
Philadelphia and RTP Katılım Mart 2009
973 Takip Edilen95.1K Takipçiler
GSK US retweetledi
News for #Investors and #Media
Watch our CEO Luke Miels as he shares our strong Q1 performance and start to 2026.
Find out more: gsk.to/3OA31JU
$GSK #Q1Results
English
@4xuHkAOxS29TACZ Hi Hussein, thanks for reaching out. We'd love to help but industry regulations mean we're not able to discuss our medicines with you. Your doctor or healthcare professional will be best placed to support. We hope this helps.
English
@GSKUS After FDA approval, when will hepatitis B treatment be available?
English
News for #Investors and #Media: Today, we announced the US Food and Drug Administration accepted our application for a potential first-in-class treatment for chronic hepatitis B. Learn more: gsk.to/4darMFN
English
Hello Anil. Thank you for reaching out to us, we understand your frustrations. Please contact our US Response Center at 888-825-5249. They are available Monday - Friday, from 8:00am to 5:30pm (EST). We hope this helps and encourage you to reach out to them for further assistance. Thank you.
English
@GSKUS That’s not true. They refer me to the finance dept and that’s the problem I am referring to. The latter asked me to send them an email with my issues. I did and it is 3 weeks +. You guys are big and can just ….
Was hoping to get help from you.
GSK US@GSKUS
@anilguptamd Hello Anil, thanks for your message. Your local GSK team will be best placed to support with your enquiry. Find out how to get in touch: gsk.com/en-gb/contact-…. We hope this helps.
English
Current treatments for #cUTIs caused by drug-resistant organisms often require hospitalization. The lack of oral treatments can result in extended hospital stays, ultimately having a negative impact on patients’ quality of life.
We remain focused to address the growing issue of antimicrobial resistance.
#ESCMIDGlobal2026
English
#News for #Investors and #Media: At #SGO2026, we presented new data on an investigational antibody-drug conjugate from our oncology pipeline. Learn more: gsk.to/47V3hJO.
English
@anilguptamd Hello Anil, thanks for your message. Your local GSK team will be best placed to support with your enquiry. Find out how to get in touch: gsk.com/en-gb/contact-…. We hope this helps.
English
@GSKUS gsk vaccines . No response from your vaccine billing department. Has been 3 weeks . I was advised to send my query by email which I did. Need help asap.
English
Our partnership with the lupus community has always been fueled by a clear purpose: to improve the outcomes for people living with lupus.
This dedication to advancing breakthroughs continues to drive our work as we look ahead to the future of lupus care.
#Lupus #AheadTogether
English
Hi, thanks for your message. We've received several reports about a recruitment scam circulating from hiring@careers-gsk.com for a Data Analyst role. We're actively investigating this, and we appreciate you bringing it to our attention. If you've received one of these emails, please help us by forwarding all relevant details and materials to askus@gsk.com. A reminder that GSK will never ask for payment at any stage of our recruitment process. Thank you for your support.
English
@shIanAtaSnu @GSKUS @shIanAtaSnu - Can you send across the email you received. Double checking. Here is what my brother received.
English
English
We‘ve topped the Access to Medicine Index's 2026 Antimicrobial Resistance Benchmark, reflecting our continuous focus on delivering innovative antibiotic medicines and vaccines for patients with significant unmet medical need.
Check out our #AMR podcast: gsk.to/4rj3UUt
English
GSK US retweetledi
Our latest Annual Report and Responsible Business Report show our progress in creating value for patients and shareholders.
Take a look at the highlights ⤵️
🔗 Investors and media can read more: gsk.to/4ubX9pQ
English
We’re on the ground at #AAAAI26, sharing our latest #RespiratoryHealth research this week. Stop by Booth 1137 to learn more. If you can’t attend, you can learn more about our work here: gsk.me/4tYOfvR 🫁
English
@hasebetomoya1 Hello. Flonase is now made by Haleon, not GSK. We encourage you to reach out with further feedback or questions via their channel @Haleon_health or their website, haleon.com/contact-us/. Sorry we couldn't be of help this time.
English
@GSK @GSKcareers @GSKUS
Strange elements like these have been detected in your company's "FluNase"！
x.com/hasebetomoya1/…
長谷部レッドブル、お～いお茶、一番搾り、コーラ、市販薬にも💉から発見されてる同様の異物を確認‼️⚠@hasebetomoya1
お疲れ様です。🙏 市販点鼻薬のフルナーゼ(ロットナンバーHP3D)を今日、某所のXRFで元素分析(先月ダイソーマスクを分析した所とは違う場所。今回のXRFの方が質が高い新式)したのですが、このような元素が⚠️⚠️🤯🤦♂️ 今まで色んな市販製品を元素分析してきましたが、間違いなくこのフルナーゼが一番強烈です。💦 ただ、製造しているグラクソ・スミスクラインは被害者多数のHPVワクチンやシングリックスを作ってる悪名高きビッグファーマですからね。まあ全然あり得る話なのかなと。🧐 念のため皆様にお伝えしておきますが、私はこの製品は全ロットがリコールされるべきと考えており、周りに働きかけています。 今回フルナーゼからXRFで検出された妙な元素 F フッ素 S 硫黄 Rb ルビジウム Sr ストロンチウム Y イットリウム Zr ジルコニウム Sb アンチモン Ba バリウム 以前、SEM－EDXで検出したと報告したテルルと臭素なのですけれども、大変申し上げ辛いのですがこれはちょっと機器の誤判定の公算が大きいと思われます。🙇♂️ SEM－EDXは基本的にあまり精度の高い機器ではないのです。。
English
GSK US retweetledi
Explore the key highlights from our Q4 and full year 2025 results announcement ⤵️
More information for media and investors: gsk.to/4a2WXQw $GSK
English
GSK US retweetledi
Watch our CEO Luke Miels as he shares our strong 2025 performance and reaffirms our long-term outlooks.
More insights and information for media and investors: gsk.to/4ti5YOs $GSK #FYResults
English
#News for #Media: Meet the Linked by Lupus: Optimal Care Initiative grant awardees; orgs working to improve early diagnosis, expand access to treatment, and strengthen patient-provider communications for those impacted by #lupus.
Read more about the grant and awardees: gsk.to/3LRfTd4
English
GSK US retweetledi
#News for #investors and #media: We’ve announced an agreement to acquire RAPT Therapeutics.
Find out more: gsk.to/3NuAT9Z
English
We're leaving #JPM2026 inspired and confident in our R&D momentum & future pipeline impact. Our approach, built on cutting-edge innovation and industry-leading partnerships, is driving us to get ahead of disease together.
#AheadTogether
English